|
| |
BIOHEART INC.Bioheart, Inc.Bioheart, Inc. is focused on the discovery, development and commercialization of cell-based therapy products for the treatment of cardiovascular diseases such as congestive heart failure (“CHF”) secondary to myocardial infarction (“MI”) and cardiovascular electrical abnormalities. The Company believes that its products hold the potential to revolutionize the treatment of cardiovascular diseases and become a new standard of care by offering treatments that improve cardiac function, are more cost-effective and are lower-risk than the current alternatives, which include heart transplantation, biventricular pacing, ventricular assist devices and certain drug therapies.
| Contact Details: |
| 13794 NW 4th Street, Suite 212 |
| Sunrise |
| Florida |
| 33325 |
| United States of America |
| Tel: | 954-835-1500 |
| Fax: | 954-845-9976 |
| Email: | hleonhardt@aol.com |
| WWW: | www.aipharma.com/
|
|
Loading...
|
Recent Publications by BIOHEART INC.: |  |
SR200 MyoCath percutaneous microimplant delivery system.
In the fall of 1945, Secretary of Commerce Henry Wallace handpicked Edward... | 1st February, 2006
| BIOHEART INC. 13794 NW 4th Street, Suite 212 Sunrise, Florida 33325, USA.
| EuroIntervention. 2006 Feb;1(4):480-1.
|
Press Releases on BIOHEART INC.:
|
 |
| Bioheart, Inc. to Present at Red Chip Investor Conference in New York |
1st August, 2008 |
Bioheart, Inc. |
SUNRISE, Fla., Aug. 1 /PRNewswire-FirstCall/ -- Bioheart, Inc.
(Nasdaq: BHRT) today announced that Howard J. Leonhardt, Chairman and CEO of
Bioheart, will present a corporate overview Thursday,
|
| Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. |
1st August, 2008 |
Bioheart, Inc. |
SUNRISE, Fla., Aug. 1 /PRNewswire-FirstCall/ -- Bioheart, Inc.,
(Nasdaq: BHRT), announced it has entered into a non-binding letter of intent
to acquire MEDICALGORITHMICS, Ltd. and the worldwide
|
| Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study |
24th July, 2008 |
Bioheart, Inc. |
SUNRISE, Fla., July 24 /PRNewswire-FirstCall/ -- Results of a preclinical
study involving the injection of myoblasts modified to express stromal derived
factor-1(alpha) protein (SDF-1) into the
|
| Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients |
11th July, 2008 |
|
SUNRISE, Florida, July 11 /PRNewswire/ -- Bioheart, Inc. (Nasdaq: BHRT), a company committed to delivering
intelligent devices and biologics that help monitor, diagnose and treat heart
failure and
|
| Bioheart, Inc., Added to Russell Microcap Index |
2nd July, 2008 |
Bioheart, Inc. |
SUNRISE, Fla., July 2 /PRNewswire-FirstCall/ -- Bioheart, Inc.
(Nasdaq: BHRT) a biotechnology company that is focused on the development of
autologous (patient-derived) cell therapies and devices
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 267 times since April 2007, the link to the organisation's website has been followed 58 times Search for more companies in Sunrise Search for more companies in Florida This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for BIOHEART INC. |
